Eli Lilly First Pharma to Reach $1 Trillion Market Cap
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
Category : Search result: Eli Lilly market capitalization
Alzheimer's Drug Donanemab Approved in India
Eli Lilly's Alzheimer's drug donanemab gets Indian regulatory approval. The treatment slows cognitive decline by 35.1% and could be available next year. Learn about its benefits and pricing.
Alzheimer's Drug Donanemab Approved for India
Eli Lilly's Alzheimer's drug donanemab gets Indian regulator nod. The treatment slows cognitive decline by 35.1% and is expected to launch in India next year. Details on pricing and safety.
SBI crosses ₹9 trillion market cap, shares trade flat
State Bank of India becomes first PSU bank to hit ₹9 trillion market capitalization. Stock trades flat after reaching lifetime high of ₹976.80. Analysts divided on near-term prospects.
Novo Nordisk Cuts Wegovy Price, Eyes Oral Pill Launch
Novo Nordisk reduces Wegovy's price to $349 and prepares an aggressive launch for its oral weight-loss pill to combat competition from Eli Lilly and expand patient access.
Top 8 firms add ₹2.05 lakh crore in market value
Bharti Airtel and Reliance Industries lead massive ₹2.05 lakh crore market cap surge as Sensex jumps 1,346 points. Discover which stocks gained most during the bullish week.
Cobra Kai: Is Hawk's Back Tattoo Real? Actor Reveals Truth
Cobra Kai's Jacob Bertrand reveals if his character Hawk's iconic back tattoo is real. Discover the show's fashion impact and fan reactions. Read more!
Medicare Deal Slashes Obesity Drug Prices for Millions
Trump administration secures obesity drug price cuts with Eli Lilly and Novo Nordisk. Medicare coverage expansion opens 30 million patient market starting April 2026. Read analysis.
Why Indian Stocks Struggle Despite Strong Economy
Discover the surprising reasons why Indian markets are struggling to reach new peaks despite robust economic growth and controlled inflation. Expert analysis reveals the hidden factors holding back the bull run.
Trump: Deal Reached to Lower Weight Loss Drug Prices
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
Big Pharma Cuts Obesity Drug Prices After Trump Pressure
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
SBI Enters $100 Billion Market Cap Club
State Bank of India creates history as it enters the prestigious $100 billion market capitalization club, with shares soaring to unprecedented highs following robust quarterly results that surpassed all expectations.
Israel-India Strengthen Ties Against Terrorism Threat
Israel's Foreign Minister Eli Cohen emphasizes growing strategic partnership with India, highlighting shared terrorism threats and expanding cooperation in defense, technology, and agriculture during crucial diplomatic meetings.
India-Israel Expand Cooperation in Trade, Agriculture & Tech
Indian and Israeli officials held high-level talks to boost cooperation in agriculture, trade, and technology during Foreign Minister Eli Cohen's strategic visit to New Delhi, marking a new chapter in bilateral relations.
Sensex Crashes 500 Points: Nifty Below 25,600
Indian stock markets witnessed massive selling pressure as Sensex crashed 500 points and Nifty ended below 25,600. Discover the 10 major factors behind today's market meltdown and what it means for investors.
FPIs Invest ₹10,000 Cr in Indian IPOs During October Frenzy
Foreign portfolio investors unleash massive capital into India's booming primary market as IPO frenzy hits new highs. Discover what's driving this unprecedented inflow and whether the rally can sustain.
4 Top Firms Add ₹95,447 Cr, Reliance Leads Rally
Four of India's top 10 most valued companies witnessed massive wealth creation totaling ₹95,447 crore last week, with Reliance Industries emerging as the biggest gainer in a bullish market sentiment.
Reliance leads India's top firms in ₹95,447 crore market cap surge
India's corporate heavyweights including Reliance Industries, TCS, HDFC Bank, and Infosys witnessed massive wealth creation as their combined market valuation surged by ₹95,447 crore last week, with Mukesh Ambani's Reliance emerging as the biggest gainer.
Nvidia's $400B Surge: AI Demand Creates History
Nvidia achieves staggering market growth, adding nearly $400 billion in value as AI revolution fuels unprecedented demand for its chips. Discover the story behind this financial milestone.
India's IPO Frenzy: ₹200 Cr/Hour Oversubscription
India's IPO market is witnessing unprecedented demand with oversubscriptions reaching ₹200 crore per hour. Discover why this boom is different from previous market frenzies and what it means for investors.
Sensex Falls 466 Points: Banking Stocks Drag Market Down
Indian stock markets extended losses as private banking giants like HDFC Bank and Kotak Mahindra faced heavy selling pressure. Discover what's driving the market downturn and which sectors are most affected.
Bandhan Bank Soars 9%, Vedanta Crashes in Market Rollercoaster
October 31 witnessed dramatic stock movements with Bandhan Bank leading gains at 9% while Vedanta, Adani Power, and Nykaa faced significant losses. Discover key sector performances and market trends.
Sensex Crashes 465 pts: Nifty Below 25,750
Indian stock markets extend losses amid global uncertainty. Sensex tanks 465 points, Nifty slips below 25,750. Discover the 10 key factors driving this market selloff and what investors should watch.
Indian Stock Markets Rebound Strongly in Early Trade
Indian equity benchmarks Sensex and Nifty witnessed a strong recovery in early trading on Tuesday, bouncing back from previous session losses as global market sentiment improved and domestic factors supported investor confidence.
Eli Lilly's Diabetes & Weight Loss Pill Replaces Injections
Eli Lilly is developing Orforglipron oral pills for weight loss and type 2 diabetes that could replace injections, making treatment more accessible and convenient for millions.
SEBI Sets New Rules for Index Derivatives Trading
SEBI introduces sweeping reforms for index derivatives, setting new criteria for stock exchanges. Discover how these changes will impact market participation and risk management.
Cognizant Plans India Listing for Higher Valuations
IT giant Cognizant explores potential India listing to tap into domestic investor base and unlock higher valuations in what could be a landmark move for the tech sector.
Eli Lilly Ups Forecast as Zepbound Demand Soars
Pharmaceutical giant Eli Lilly raises full-year profit forecast as demand skyrockets for revolutionary weight-loss treatment Zepbound, sending shares climbing 7%.
Sensex Crashes 593 Points Amid Foreign Fund Outflows
Indian stock markets witnessed heavy selling as foreign portfolio investors pulled out funds and global uncertainty over US Federal Reserve's rate cut timeline sparked panic. The Sensex dropped 593 points while Nifty fell below 21,800.
Nifty 50, Sensex Outlook: US Fed Impact on Indian Stocks
Indian stock markets brace for volatility as US Federal Reserve's rate cut decision looms. Get expert analysis on Nifty 50 and Sensex movement for October 30 trading session.
Page 2 of 4